OpenAlex
PricingAboutJobs
Log inGet started
Work

EGFR TKI combination with immunotherapy in non-small cell lung cancer

HTML

Year: 2017
Type: review
Source: Expert Opinion on Drug Safety
DOI: 10.1080/14740338.2017.1300656
Authors: Myung-Ju Ahn, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park
Institutions: Samsung Medical Center, Sungkyunkwan University
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: EGFR tyrosine kinase inhibitors, immunotherapy, non-small cell lung cancer, anti-PD-1 therapy, acquired drug resistance, EGFR mutation, nivolumab, erlotinib, osimertinib, durvalumab, gefitinib, atezolizumab, interstitial lung disease, elevated liver enzymes, treatment-related adverse events
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2593630992
FWCI: 4.381
Cites: 31
Cited by: 176
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms